Literature DB >> 15025424

Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis.

B Gudbjörnsson1, R Christofferson, A Larsson.   

Abstract

OBJECTIVES: To investigate whether concentrations of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in aspirated synovial fluid can be used to distinguish rheumatoid arthritis from other forms of inflammatory arthritis.
METHODS: bFGF and VEGF concentrations were measured in aspirated synovial fluid and serum samples from 66 patients with active arthritis (clinical diagnoses: rheumatoid arthritis (35 patients), psoriatic arthritis (9), reactive arthritis (11) and arthritis UNS (11)) utilizing commercial ELISA kits.
RESULTS: In comparison with controls, elevated concentrations of VEGF were found in synovial fluid compared with in serum in all forms of arthritis. There were no significant differences in synovial fluid bFGF or VEGF concentrations between rheumatoid arthritis and the other forms of inflammatory arthritis.
CONCLUSION: Both serum bFGF and VEGF concentrations were increased in patients with rheumatoid arthritis. Patients treated with steroids had lower synovial fluid bFGF concentrations. Synovial fluid levels of bFGF and VEGF were elevated but could not be used to distinguish rheumatoid arthritis from other forms of inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025424     DOI: 10.1080/00365510410003732

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  9 in total

1.  Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides.

Authors:  Mahmut Gok; Hakan Erdem; Feride Gogus; Sedat Yilmaz; Omer Karadag; Ismail Simsek; Rahsan Ilikci Sagkan; Mutlu Saglam; Ugur Musabak; Ayhan Dinc; Salih Pay
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

2.  [Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative].

Authors:  I H Tarner; K Albrecht; M Fleck; E Gromnica-Ihle; G Keyßer; L Köhler; I Kötter; K Krüger; J Kuipers; H Nüßlein; A Rubbert-Roth; J Wollenhaupt; M Schneider; B Manger; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

3.  Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression.

Authors:  Sandra I Zittermann; Andrew C Issekutz
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

4.  Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients.

Authors:  Yesuf Taha; Yngve Raab; Marie Carlson; Anders Larsson; Mikael Lördal; Lars Lööf; Magnus Thörn
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

5.  VEGF Profile in Early Undifferentiated Arthritis Cohort.

Authors:  Regina Sakalyte; Loreta Bagdonaite; Sigita Stropuviene; Sarune Naktinyte; Algirdas Venalis
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

Review 6.  Platelet-rich plasma for managing pain and inflammation in osteoarthritis.

Authors:  Isabel Andia; Nicola Maffulli
Journal:  Nat Rev Rheumatol       Date:  2013-10-01       Impact factor: 20.543

7.  Increased serum VEGF and b-FGF in Graves' ophthalmopathy.

Authors:  Xiaozhen Ye; Jun Liu; Yangtian Wang; Lu Bin; Jian Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-28       Impact factor: 3.117

Review 8.  Modulation of angiogenesis with siRNA inhibitors for novel therapeutics.

Authors:  Patrick Y Lu; Frank Y Xie; Martin C Woodle
Journal:  Trends Mol Med       Date:  2005-03       Impact factor: 11.951

9.  Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer.

Authors:  Ananaya Datta-Mitra; Navdeep K Riar; Siba P Raychaudhuri
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.